CUE Substantial Shareholders Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Woodside Energy Group Ltd (CUE). However, you won't necessarily ...

Novartis closes on filings for oral BTK drug remibrutinib as a treatment for chronic spontaneous urticaria after reporting 52-week data.

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year ...

This article proposes a monocular point-line visual-inertial odometry (VIO) with line filtering and fast line matching (FLM PL-VIO), improving the localization accuracy and robustness. Different from ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

AIM To study the effects of supervised inpatient occlusion treatment for amblyopia in children who had failed to respond to outpatient treatment. METHODS A retrospective study of 39 children admitted ...